Condition: Obesity · Sponsor: BioAge Labs, Inc.
This study aims to find out how well a combination of oral azelaprag taken once a day (QD) or twice a day (BID), along with a weekly injection of tirzepatide, works for weight management in adults 55 years and older. The researchers are also looking at safety. Estimated Study Length: * with the optional prescreening, the study duration may be up to 48 weeks. * the treatment duration will be 24 weeks followed by 12 weeks follow-up. * the visit frequency will be every 2 weeks for the first 8 weeks of the treatment period and every 4 weeks thereafter.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Site 110 | Mesa, Arizona, United States | — |
| Site 107 | Los Angeles, California, United States | — |
| Site 103 | Montclair, California, United States | — |
| Site 105 | Spring Valley, California, United States | — |
| Site 100 | Louisville, Kentucky, United States | — |
| Site 101 | Marrero, Louisiana, United States | — |
| Site 112 | Boston, Massachusetts, United States | — |
| Site 111 | Troy, Michigan, United States | — |
| Site 113 | City of Saint Peters, Missouri, United States | — |
| Site 106 | Butte, Montana, United States | — |
| Site 109 | Fargo, North Dakota, United States | — |
| Site 108 | Beachwood, Ohio, United States | — |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06515418